| 000 | 01887 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516084635.0 | ||
| 264 | 0 | _c20130208 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1742-7843 | ||
| 024 | 7 |
_a10.1111/j.1742-7843.2012.00892.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKim, In-Wha | |
| 245 | 0 | 0 |
_aIdentification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients. _h[electronic resource] |
| 260 |
_bBasic & clinical pharmacology & toxicology _cOct 2012 |
||
| 300 |
_a217-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aGraft Rejection |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Transplantation _xmethods |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aRepublic of Korea |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTacrolimus _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aNoh, Hyejin | |
| 700 | 1 | _aJi, Eunhee | |
| 700 | 1 | _aHan, Nayoung | |
| 700 | 1 | _aHong, Su Hyun | |
| 700 | 1 | _aHa, Jongwon | |
| 700 | 1 | _aBurckart, Gilbert J | |
| 700 | 1 | _aOh, Jung Mi | |
| 773 | 0 |
_tBasic & clinical pharmacology & toxicology _gvol. 111 _gno. 4 _gp. 217-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1742-7843.2012.00892.x _zAvailable from publisher's website |
| 999 |
_c21671731 _d21671731 |
||